Reuters logo
BRIEF-Biocartis H1 total operating income up at 6.8 million euros
September 7, 2017 / 6:11 AM / 3 months ago

BRIEF-Biocartis H1 total operating income up at 6.8 million euros

Sept 7 (Reuters) - BIOCARTIS GROUP NV:

* H1 RESULTS‍​

* H1 TOTAL OPERATING INCOME EUR 7.0 MILLION VERSUS EUR 6.8 MILLION YEAR AGO

* CASH AND CASH EQUIVALENTS OF EUR 59.0M AS PER END H1 2017‍​

* H1 TOTAL REVENUE EUR 5.9 MILLION VERSUS EUR 6.1 MILLION YEAR AGO

* H1 NET LOSS EUR 24.0 MILLION VERSUS LOSS OF EUR 23.8 MILLION YEAR AGO

* OPERATIONAL LOSS EUR 23.7 MILLION VERSUS LOSS OF EUR 24.0 MILLION YEAR AGO

* GUIDANCE FOR 2017 FY REITERATED

* EXPECTED TEST MENU NEWS FLOW IN H2 2017: CE-MARKING IDYLLA CTKRAS MUTATION TEST AND IDYLLA CTNRAS-BRAF MUTATION TEST

* EXPECTED TEST MENU NEWS FLOW IN H2 2017: LAUNCH OF A LIQUID BIOPSY VERSION OF IDYLLA CTEGFR MUTATION ASSAY (RUO) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below